Contrast ‐enhanced CT‐based radiomic analysis for determining the response to anti‐programmed death‐1 therapy in esophageal squamous cell carcinoma patients: A pilot study

ConclusionsThe combined model incorporating radiomic features and clinical CECT predictors helps to predict the response to anti-PD-1therapy in patients with ESCC.

Source: Thoracic Cancer - September 25, 2023 Category: Cancer & Oncology Authors: Qinzhu Yang, Haofan Huang, Guizhi Zhang, Nuoqing Weng, Zhenkai Ou, Meili Sun, Huixing Luo, Xuhui Zhou, Yi Gao, Xiaobin Wu Tags: ORIGINAL ARTICLE Source Type: research